Malondialdehyde level in chronic obstructive pulmonary disease exacerbations

Natalja Voskresenska, Julija Voicehovska, Aleksandra Vojcehovska, Grigorijs Orlikovs, Andrejs Skesters

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

Chronic obstructive pulmonary disease (COPD) exacerbations are associated with increased inflammation followed by oxidative stress (OS). Malondialdehyde (MDA) negatively correlation with PFT was demonstrated (Upasana J. et al. ERJ vol. 44 no. Suppl 58 P3958) In patients who survive their first COPD-related hospitalization up to 50% have been reported for re-admission within 6 months of discharge. Up to 84% of direct costs associated with COPD are due to inpatient hospitalizations.
Original languageEnglish
Article numberOA2920
JournalEuropean Respiratory Journal
Volume46
Issue numberS59
DOIs
Publication statusPublished - 1 Sep 2015
Event European Respiratory Society International Congress - Amsterdam, Netherlands
Duration: 26 Sep 201530 Sep 2015

Keywords

  • Biomarkers
  • COPD - exacerbations
  • Monitoring

Field of Science

  • 3.2 Clinical medicine

Publication Type

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'Malondialdehyde level in chronic obstructive pulmonary disease exacerbations'. Together they form a unique fingerprint.

Cite this